CME Group Inc. (NASDAQ:CME) has been assigned an average recommendation of “Hold” from the thirteen brokerages that are presently covering the firm. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and five have assigned a buy rating to the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $102.21.

Several brokerages have recently commented on CME. Credit Agricole SA decreased their target price on CME Group from $100.00 to $95.00 and set an “underperform” rating on the stock in a report on Thursday, July 14th. Keefe, Bruyette & Woods upped their price target on CME Group from $99.00 to $103.00 and gave the company a “market perform” rating in a research note on Friday, July 29th. Deutsche Bank AG upped their price target on CME Group from $111.00 to $112.00 and gave the company a “buy” rating in a research note on Friday, August 5th. Barclays PLC cut their price target on CME Group from $100.00 to $99.00 and set an “equal weight” rating on the stock in a research note on Friday, July 29th. Finally, Zacks Investment Research raised CME Group from a “hold” rating to a “buy” rating and set a $116.00 price target on the stock in a research note on Thursday, August 4th.

CME Group (NASDAQ:CME) traded up 0.38% during trading on Wednesday, reaching $104.32. The company’s stock had a trading volume of 400,192 shares. The firm has a market cap of $35.35 billion, a P/E ratio of 26.34 and a beta of 0.83. The stock’s 50 day moving average is $106.59 and its 200-day moving average is $99.56. CME Group has a 52 week low of $81.87 and a 52 week high of $110.35.

CME Group (NASDAQ:CME) last announced its earnings results on Thursday, July 28th. The company reported $1.14 EPS for the quarter, topping the consensus estimate of $1.11 by $0.03. The company had revenue of $906 million for the quarter, compared to analysts’ expectations of $897.84 million. CME Group had a return on equity of 6.83% and a net margin of 38.22%. The business’s revenue for the quarter was up 10.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.95 earnings per share. On average, equities research analysts forecast that CME Group will post $4.43 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Monday, September 26th. Shareholders of record on Friday, September 9th were issued a $0.60 dividend. The ex-dividend date was Wednesday, September 7th. This represents a $2.40 annualized dividend and a dividend yield of 2.31%. CME Group’s dividend payout ratio (DPR) is currently 60.61%.

In related news, insider Bryan T. Durkin sold 15,000 shares of the stock in a transaction dated Tuesday, September 6th. The stock was sold at an average price of $107.75, for a total transaction of $1,616,250.00. Following the completion of the transaction, the insider now directly owns 63,967 shares in the company, valued at $6,892,444.25. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Bryan T. Durkin sold 14,990 shares of the stock in a transaction dated Wednesday, September 28th. The stock was sold at an average price of $105.10, for a total value of $1,575,449.00. Following the transaction, the insider now owns 66,936 shares of the company’s stock, valued at $7,034,973.60. The disclosure for this sale can be found here. 0.61% of the stock is owned by company insiders.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Bank of Montreal Can bought a new position in CME Group during the second quarter worth $35,643,000. Legal & General Group Plc increased its position in CME Group by 2.0% in the first quarter. Legal & General Group Plc now owns 1,391,482 shares of the company’s stock worth $133,643,000 after buying an additional 27,322 shares in the last quarter. AMP Capital Investors Ltd increased its position in CME Group by 10.6% in the first quarter. AMP Capital Investors Ltd now owns 278,973 shares of the company’s stock worth $26,661,000 after buying an additional 26,751 shares in the last quarter. UMB Bank N A MO increased its position in CME Group by 5.8% in the second quarter. UMB Bank N A MO now owns 177,713 shares of the company’s stock worth $17,309,000 after buying an additional 9,775 shares in the last quarter. Finally, Strs Ohio increased its position in CME Group by 5.2% in the second quarter. Strs Ohio now owns 234,783 shares of the company’s stock worth $22,867,000 after buying an additional 11,596 shares in the last quarter. Institutional investors and hedge funds own 80.29% of the company’s stock.

CME Group Company Profile

CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.

5 Day Chart for NASDAQ:CME

Receive News & Stock Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related stocks with our FREE daily email newsletter.